Recent outperformance has been driven by investments in ADP, Lowe's, Starbucks and Chipotle, according to the activist investor.
CNBC's Leslie Picker discusses Caesars' stock jump after billionaire Carl Icahn takes a stake in the gambling giant, according to sources. Last year, Tilman Fertitta, owner of the Houston Rockets and Landry’s, proposed a deal of $13 cash and stock for Caesars. Shares of Caesars jumped in early trading on Friday after falling 46 percent last year.
CNBC's David Faber reports on investor Carl Icahn building a stake in casino company. The size of Icahn’s stake is not immediately known. Caesars shares jumped 6.8 percent on Friday.
CNBC's 'Squawk on the Street' team discuss Dell shareholders approving the share buyout of DVMT which could lead to Dell becoming a public company once again.
It's especially important to remember when the markets are volatile.
People think billionaires take giant risks to get where they are, but most of them don't, says Tony Robbins.
CNBC's David Faber reports on Dell's new offer for its tracking stock.
CNBC's 'Squawk Box' team discuses the latest the fight between Carl Ichan and Micheal Dell over tracking stock VMware.
Rather than wasting cash and energy in offering public investors growth, companies like Kellogg and General Mills would maybe be better off going private.
CNBC's David Faber reports on Carl Icahn uping his stake in the technology company in an attempt to block the company's plan to return to the public market without an IPO.
CNBC's 'Squawk Box' team discusses Carl Ichan's letter urging voters to vote against the takeover bid.
The 'Squawk on the Street' team discuss Carl Icahn's decision to drop his fight with the Cigna-Express Scripts deal.
Carl Icahn dropped his fight against the Cigna-Express Scripts deal citing the crossover was too big.
Glenview Capital's Larry Robbins is defending Cigna's deal to acquire Express Scripts.
Jim Cramer explains why Tesla's short-sellers might be up against "the greatest short-buster in modern memory" in Elon Musk.
Icahn's searing letter opposing Cigna's $54 billion acquisition of pharmacy benefit manager Express Scripts says the "folly ... may well become one of the worst blunders in corporate history."
David Cordani, Cigna CEO, discusses the company's deal for Express Scripts and investor Carl Icahn's open letter to shareholders against it.
Cigna defended the deal, saying it would "create tremendous value for shareholders, accelerate the transformation of healthcare and address the dynamic regulatory environment for health services."
The "Squawk on the Street" news team discusses Carl Icahn's letter to Cigna shareholders about the company's plan to acquire Express Scripts.
Icahn urged Cigna shareholders to vote against the health insurer's $52 billion acquisition of Express Scripts.